Marco Bolis

[Marco Bolis @MBolisDr]

Our paper is now online! Thanks to everyone who has contributed! Congrats!

[Nature Communications @NatureComms]

Transcriptome atlas of #ProstateCancer and cell lines, patient-derived #xenografts and #scRNAseq reveal roles of #EZH2 and macrophage polarisation

#CancerResearch by @MBolisDr @JTheurillat @DidyBossi @VallergaArianna @Danida0 @LauraDiRitoMN
@NatResCancer

https://t.co/i3VWWQnC0Q

[Institute of Oncology Research (IOR) @IOR_Bellinzona]

🎖Congratulations to the lymphoma teams of the IOR and the IOSI (@EnteOspedaliero) for their review on marginal zone #lymphoma published in the @NEJM .

📃Read the review: https://t.co/JOgsd2bEZx
📢Read the news: https://t.co/bQwLCY7isF

@USI_en
@frbertoni

[Cancer Discovery @CD_AACR]

In the January issue of Cancer Discovery, Hallmarks of Cancer-New Dimensions. https://t.co/qcopTAZNmu
Douglas Hanahan, @Ludwig_Cancer

[Institute of Oncology Research (IOR) @IOR_Bellinzona]

🧬Researchers of the Functional Cancer Genomics Group at the IOR, led by @JTheurillat, developed a novel method to track precisely prostate cancer progression.

📰Read the news: https://t.co/3vwP2miOOW
🔬Article published on @NatureComms: https://t.co/zCkbvzBS1z

@MbolisDr

[Nature Communications @NatureComms]

Transcriptome atlas of #ProstateCancer and cell lines, patient-derived #xenografts and #scRNAseq reveal roles of #EZH2 and macrophage polarisation

#CancerResearch by @MBolisDr @JTheurillat @DidyBossi @VallergaArianna @Danida0 @LauraDiRitoMN
@NatResCancer

https://t.co/i3VWWQnC0Q

[Mark A. Rubin @MarkARubin1]

This paper gives us a lot to think about...Congrats Andrea and team! @PCFnews @APCCC_Lugano @ETH @SPHN_ch

[Marco Bolis @MBolisDr]

@Buljubasic_Amar @radiosarajevo Thank you for supporting us